Response to Zhou et al. Osteomalacia is a frequent complication resulting from long-term therapy with drugs such as phenytoin, carbamazepine, and phenobarbital.
Pascussi
Jean-Marc
JM
Maurel
Patrick
P
Vilarem
Marie-José
MJ
D000927:Anticonvulsants / Q000009:adverse effects* / Q000627:therapeutic use; D002220:Carbamazepine / Q000009:adverse effects / Q000627:therapeutic use; D000090702:Constitutive Androstane Receptor; D015870:Gene Expression / Q000187:drug effects; D006801:Humans; D010018:Osteomalacia / Q000139:chemically induced*; D010634:Phenobarbital / Q000009:adverse effects / Q000627:therapeutic use; D010672:Phenytoin / Q000009:adverse effects / Q000627:therapeutic use; D000077297:Pregnane X Receptor; D018167:Receptors, Calcitriol / Q000235:genetics / Q000378:metabolism; D018160:Receptors, Cytoplasmic and Nuclear / Q000235:genetics / Q000378:metabolism; D011987:Receptors, Steroid / Q000235:genetics / Q000378:metabolism; D013250:Steroid Hydroxylases / Q000235:genetics / Q000378:metabolism; D014157:Transcription Factors / Q000235:genetics / Q000378:metabolism; D065668:Vitamin D3 24-Hydroxylase
D000927:Anticonvulsants; D000090702:Constitutive Androstane Receptor; D000077297:Pregnane X Receptor; D018167:Receptors, Calcitriol; D018160:Receptors, Cytoplasmic and Nuclear; D011987:Receptors, Steroid; D014157:Transcription Factors; D002220:Carbamazepine; D010672:Phenytoin; D013250:Steroid Hydroxylases; D065668:Vitamin D3 24-Hydroxylase; D010634:Phenobarbital